Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes.

摘要: Diabetes and cancer are common, chronic, potentially fatal diseases that frequently co-exist. Observational studies have reported an increased risk of in patients with diabetes. Furthermore, many already diabetes, or develop hyperglycaemia as a consequence the tumor therapies, coexisting diabetes confers greater mortality for malignancies. Managing oncologic is often complicated, since co-existence poses several complex clinical questions: what level glycaemic control to achieve, which therapy use, how deal glucocorticoid therapies artificial nutrition, complications can affect management, drug-drug interactions should be taken into account, even manage at end life. In setting, both hospital home, there little agreed, evidence-based guidelines on best management criteria upon decisions based. A practical solution lies implementation care networks based communication ongoing collaboration between Oncologists, Endocrinologists, nursing staff, patient centre process. This manuscript aims review current evidence effect glucose metabolism address some more common challenges treatment cancer.